Case nobody else receives this (I doubt that) -- Fwd: eNEWS: 2 more MS pills stir excitement

[Guest guest]

---

eNEWS: 2 more MS pills stir excitement

Date:

Sat, 14 May 2011 09:00:51 -0500 (CDT)

From:

National MS Society

Reply-To:

National MS Society

Organization:

National MS Society

To:

donnaisalwayz@...

National MS Society

Email not displaying

correctly? View

it in your browser.

In a recent press

release, Biogen Idec reported that their oral

MS disease-modifier, BG-12, significantly

reduced the number of people with MS who had

relapses during a two-year study of more than

1,200 people with MS. At the annual meeting of

the American Academy of Neurology in April,

Teva Pharmaceuticals reported that their oral

MS therapy, laquinimod, reduced the relapse

rate in those taking the drug in a study of

1,106 people with MS. Both companies are

awaiting the results of other phase III trials

involving these therapies before submitting

applications to the FDA.

More on BG-12

Laquinimod at AAN

Hahn’s research

is personal

May 25 is World MS

Day. Join the global movement and

share what MS= to you.

Read the latest on

vitamin D research, progressive MS, getting

back into the workforce and more: The Summer

issue of Momentum is now LIVE online in our

new fully interactive digital edition. Comment

on stories and on other readers’ comments,

download pages as PDFs, share stories via

e-mail or social media. Read on laptop,

iPhone, iPad, Android or an e-reader with

Internet connection.

Get Momentum now

Thanks to a generous

gift from Pure Protein®, national sponsor and

maker of high-quality protein bars, your

donation will be immediately matched and put

to work moving us closer to a world free of

MS. For a limited time only, your donation

will be matched dollar for dollar.

May 3:

Study of oral teriflunomide and interferon

beta recruiting people with relapsing forms

of MS worldwide

April 26: Recent

mouse studies may provide new targets to

stop MS

Read more about these and

other recent reports

This communication is partially

sponsored through the generous support of

Biogen Idec;

EMD Serono and Pfizer, Inc; Novartis

Pharmaceuticals Corporation; and Teva

Neuroscience, Inc.

National

MS Society | View

as Web page | Subscribe

| Legal

Notice/Privacy Policy | Email

Preferences | Unsubscribe

MS

stops people from moving. The National MS

Society exists to make sure it doesn’t. We are

a collective of passionate individuals, moving

together to create a world free of MS.

JOIN THE MOVEMENT®

Please

do not reply to this email as we are unable to

quickly respond to messages sent to this

address. To receive information about living

with MS, Bike MS or Walk MS — or to contact

National MS Society staff in your area —

please

visit our Web site.

Early

and ongoing treatment with an FDA-approved

therapy can make a difference for people with

multiple sclerosis. Learn about your options

by talking to your health care professional

and contacting the National MS Society at http://www.nationalmssociety.org/

or 1-.

National

Multiple Sclerosis Society | 733 Third Avenue

| New York, NY | 10017

This message was sent to

donnaisalwayz@....

To ensure that you continue to receive our

emails, please add us to your address book.